Literature DB >> 15371813

Lower urinary tract symptoms: shifting our focus from the prostate to the bladder.

Mike B Siroky1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15371813     DOI： 10.1097/01.ju.0000139987.77928.da

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  4 in total

Review 1.  The future of bladder research: molecular profiling, new drug targets, gene therapy, and tissue engineering.

Authors:  George Christ; Karl-Erik Andersson; Anthony Atala
Journal:  Curr Urol Rep       Date:  2007-03       Impact factor: 3.092

Review 2.  New intraprostatic injectables and prostatic urethral lift for male LUTS.

Authors:  Giuseppe Magistro; Christian G Stief; Christian Gratzke
Journal:  Nat Rev Urol       Date:  2015-07-21       Impact factor: 14.432

3.  Phosphodiesterase type 5 (PDE5) is co-localized with key proteins of the nitric oxide/cyclic GMP signaling in the human prostate.

Authors:  Stefan Ückert; Eginhard S Waldkirch; Axel S Merseburger; Markus A Kuczyk; Matthias Oelke; Petter Hedlund
Journal:  World J Urol       Date:  2013-03-09       Impact factor: 4.226

4.  17Beta-estradiol affects the proliferation and apoptosis of rat bladder neck smooth muscle cells by modulating cell cycle transition and related proteins.

Authors:  Wafi Waladali; Yi Luo; Wen S Li; Min X Zheng; Quan L Hu
Journal:  World J Urol       Date:  2008-10-10       Impact factor: 4.226
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.